MSeqDR Mitochondrial Disease Portal


 
*:HP: HPO terms, ND: NAMDC terms.
  Most Studied  CPEO, Complex I Deficiency, COXPD1, Leigh, LHON, MELAS, MERRF, NARP, SANDO
Disease Browser
Parent Node:
expand
mitochondrial oxidative phosphorylation disorder (MONDO:0016387)
..Starting node
..expand
mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies ()

       Child Nodes:
........expandCharcot-Marie-Tooth disease recessive intermediate d ()
........expandCharcot-Marie-Tooth disease type 4K ()
........expandcoenzyme Q10 deficiency ()
........expandcongenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome ()  LSDB  L: 00045;
........expandfatal infantile encephalocardiomyopathy ()
........expandLeigh disease ()
........expandlethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome ()  LSDB  L: 00522;
........expandmitochondrial disorder due to a defect in assembly or maturation of the respiratory chain complexes ()
........expandmitochondrial disorder due to a defect in mitochondrial protein synthesis ()
........expandmitochondrial DNA maintenance syndrome ()
........expandmitochondrial oxidative phosphorylation disorder with no known mechanism ()
........expandpancreatic insufficiency-anemia-hyperostosis syndrome ()



 Sister Nodes: 
..expandcombined oxidative phosphorylation deficiency ()
..expandisolated oxidative phosphorylation complex disorder ()
..expandmitochondrial oxidative phosphorylation disorder due to mitochondrial DNA anomalies ()
..expandmitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies ()
   

MONDO is developed by the Monarch Initiative. Human Disease MESH is developed by UMLS.
Further data from MedGen, OMIM,ClinVar, CTD
Term ID:16578
Name:mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies
Definition:Mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies is a group of clinically heterogeneous diseases, commonly defined by lack of cellular energy due to defects of oxidative phosphorylation (OXPHOS), resulting from pathogenic mutations in the nuclear DNA. Mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies includes diseases classified according to defects in: genes encoding structural components of OXPHOS complexes (such as Leigh syndrome, coenzyme Q10 deficiency); genes encoding assembly factors of OXPHOS complexes (such as GRACILE syndrome); genes altering the stability of mitochondrial DNA (such as autosomal dominant progressive external ophthalmoplegia, mitochondrial DNA depletion syndrome); mitochondrial protein synthesis (see these terms).
Alternative IDs:
ParentIDs:
TreeNumbers:
Synonyms:mitochondrial oxidative phosphorylation disorder due to nDNA anomalies; OXPHOS disease due to nDNA anomalies; OXPHOS disease due to nuclear DNA anomalies
Slim Mappings:
Reference: MedGen:
MeSH:
OMIM:
MSeqDR LSDB:  
Genes:
Phenotypes
Disease Causing ClinVar Variants
MSeqDR Portal